Federal award (DEFINITIVE CONTRACT, fiscal year 2022)
Recipient: MINISTRY OF DEFENCE
Awarding agency: Department of Defense / Defense Threat Reduction Agency
Funding agency: Department of Defense / Defense Threat Reduction Agency
Period of performance: 2020-06-15 to 2024-01-14
Current total value of award: $694900.74
Description: PHARMACOLOGICAL AND BIOLOGIC INTERVENTION TO REDUCE INFLAMMATION AND SEIZURES CAUSED BY VIRAL ENCEPHALITIS